OnKure Therapeutics
(NASDAQ) OKUR
OnKure Therapeutics Financials at a Glance
Market Cap
$59.89M
Revenue (TTM)
$0.00
Net Income (TTM)
$59.52M
EPS (TTM)
$-4.40
P/E Ratio
-0.99
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$4.18
Volume
41,698
Open
$4.65
Price
$4.18
Volume
41,698
Open
$4.65
Previous Close
$4.18
Daily Range
$4.11 - $4.68
52-Week Range
$1.70 - $5.10
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$4.18
Volume
41,698
Open
$4.65
Previous Close
$4.18
Daily Range
$4.11 - $4.68
52-Week Range
$1.70 - $5.10
OKUR News
OKUR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout OnKure Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
45
CEO
Nicholas A. Saccomano, PhD
Website
onkuretherapeutics.comHeadquarters
Boulder, CO 80301, US
OKUR Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-74%
Return on Capital
-1%
Return on Assets
-96%
Earnings Yield
-1.01%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$59.89M
Shares Outstanding
13.67M
Volume
41.70K
Short Interest
0.00%
Avg. Volume
122.40K
Financials (TTM)
Gross Profit
$830.00K
Operating Income
$62.95M
EBITDA
$62.12M
Operating Cash Flow
$51.83M
Capital Expenditure
$46.00K
Free Cash Flow
$51.87M
Cash & ST Invst.
$59.05M
Total Debt
$549.00K
OnKure Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$202.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$59.89M
N/A
Market Cap/Employee
$1.30M
N/A
Employees
46
N/A
Net Income
$13.50M
+61.6%
EBITDA
$15.66M
+49.7%
Quarterly Fundamentals
Net Cash
$58.50M
-46.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$549.00K
+2.4%
Return on Assets
-95.81%
N/A
Return on Invested Capital
-1.12%
N/A
Free Cash Flow
$11.52M
+45.3%
Operating Cash Flow
$11.51M
+45.2%